Expertise in
4
conditions

Gen B. Lin

Fuzhou, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Fuzhou, CN 

Overview

Gen Lin practices practicing medicine in Fuzhou, China.

Lin is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, Thymic Epithelial Tumor, and Lung Transplant.

They are actively involved in clinical research, co-authoring 79 peer reviewed articles and participating in 1 clinical trial.

Locations

Fuzhou, 350014, China
Other Locations
Beijing, China
Key Laboratory Of Bioactive Substances And Resources Utilization Of Chinese Herbal Medicine, Chinese Academy Of Medical Sciences And Peking Union Medical College, 151 Malianwa North Road, Haidian, 100193, China
350005, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Enrollment Status: Recruiting
Publish Date: April 03, 2026
Intervention Type: Drug
Study Drug: Repotrectinib
Study Phase: Phase 1/Phase 2

79 Total Publications

Expert consensus on the detection and clinical application of tumor mutational burden.
Expert consensus on the detection and clinical application of tumor mutational burden.
Journal: Cancer biology & medicine
Published: February 18, 2026

Frequently Asked Questions about Gen B. Lin

Is Gen B. Lin a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Gen B. Lin is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gen B. Lin participate in research or clinical trials?

Yes. Gen B. Lin has published 79 articles and abstracts on conditions like Lung Cancer. You can view a list of Gen B. Lin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lin's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile